989 top medical experts on AIDS-Related Opportunistic Infections across 73 countries and 35 U.S. states, including 892 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. AIDS-Related Opportunistic Infections: Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include pneumocystis pneumonia, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): HIV Infections (5,486), Opportunistic Infections (2,029).
  4. Clinical Trials ClinicalTrials.gov : at least 5 including 2 Completed, 1 Recruiting
  5. Synonyms: HIV-Related Opportunistic Infections,  HIV-Related Opportunistic Infections


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Boulware, David R   Infectious Disease  Google Publications
    Department of Medicine, Medical School, University of Minnesota, Minneapolis, MN, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 85/100
    Subjects: Meningitis, Cryptococcal; Antigens, Fungal; HIV Infections; Antifungal Agents; Cryptococcus
    Categories: Diagnosis; Drug Therapy; Therapeutic Use; Immunology; Administration & Dosage; Mortality
    Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. (2014)
    Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast. (2014)

  2. Swindells, Susan   Infectious Disease  Google Publications
    University of Nebraska Medical Center, Omaha, NE, USA.
    Physician  Highly Cited  Clinical Trial 
    Subjects: Anti-Retroviral Agents; Antitubercular Agents; HIV Infections; HIV-1; Tuberculosis
    Categories: Drug Therapy; Administration & Dosage; Prevention & Control; Analogs & Derivatives; Diagnosis; Therapeutic Use
    Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. (2014)
    Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. (2011)

  3. Friedland, Gerald H   Infectious Disease  Google Publications
    Yale School of Medicine, New Haven, CT, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 68/100
    Subjects: HIV Infections; Tuberculosis; Anti-Retroviral Agents; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis
    Categories: Drug Therapy; Mortality; Therapeutic Use; Administration & Dosage; Epidemiology; Microbiology
    Timing of initiation of antiretroviral drugs during tuberculosis therapy. (2010)
    Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. (2010)

  4. Chaisson, Richard E   Infectious Disease   Google Publications
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, United States. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Disclosed payments from biomedical company (Janssen Research & Development, LLC) in 2021 for $3,720
    Subjects: Tuberculosis; HIV Infections; Antitubercular Agents; Isoniazid; Rifampin
    Categories: Drug Therapy; Therapeutic Use; Prevention & Control; Mortality; Administration & Dosage; Diagnosis
    One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. (2019)
    New regimens to prevent tuberculosis in adults with HIV infection. (2011)

  5. Reid, Erin G   Hematology & Oncology   Google Publications
    University of California, San Diego Moores Cancer Center, La Jolla, California. . Top Hospital
    Physician  Guideline  Clinical Trial 
    Medical school: University of California, San Francisco School of Medicine (MD, 1999)
    Medicare Accepted
    Disclosed payments from biomedical company (Epizyme, Inc.,) in 2021 for $11.5
    Subjects: Sarcoma, Kaposi; Antineoplastic Agents; Benzamides; Bortezomib; Endothelial Cells
    Categories: Therapeutic Use; Drug Therapy; Diagnosis; Therapy; Isolation & Purification; Pathology
    Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042. (2014)
    AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. (2019)

  6. Havlir, Diane V   Internal Medicine   Google Publications
    Zuckerberg San Francisco General Hopsital and University of California San Francisco, San Francisco, CA, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 70/100
    Subjects: HIV Infections; Tuberculosis; Anti-Retroviral Agents; Acquired Immunodeficiency Syndrome; Anti-HIV Agents
    Categories: Drug Therapy; Complications; Therapeutic Use; Epidemiology; Diagnosis; Prevention & Control
    Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. (2014)
    Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. (2011)

  7. Gupta, Amita   Infectious Disease  Google Publications
    Center for Clinical Global Health Education and Center for Tuberculosis Research, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States. Top Hospital
    Physician  Highly Cited  Clinical Trial 
    Disclosed payments from biomedical company (Gilead Sciences, Inc.) in 2021 for $24.56
    Subjects: Tuberculosis; Antitubercular Agents; Isoniazid; Anti-Retroviral Agents; HIV Infections
    Categories: Prevention & Control; Therapeutic Use; Blood; Drug Therapy; Administration & Dosage; Complications
    One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. (2019)
    Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. (2019)

  8. Janoff, Edward N   Infectious Disease   Google Publications
    Mucosal and Vaccine Research Program Colorado, Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, CO .
    Physician  Clinical Trial 
    Disclosed payments from biomedical company (Merck Sharp & Dohme Corporation) in 2021 for $2,250
    Subjects: Acquired Immunodeficiency Syndrome; Meningitis, Cryptococcal; Mycoses; Adaptive Immunity; Anti-HIV Agents
    Categories: Immunology; Drug Therapy; Epidemiology; Physiopathology; Prevention & Control; Therapeutic Use
    Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. (2014)
    The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum. (2016)

  9. Manabe, Yukari C   Internal Medicine   Google Publications
    Johns Hopkins University School of Medicine, Baltimore, MD, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: HIV Infections; Tuberculosis; Acquired Immunodeficiency Syndrome; Cryptococcosis; Meningitis, Cryptococcal
    Categories: Diagnosis; Drug Therapy; Therapeutic Use; Complications; Epidemiology; Genetics
    Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. (2014)
    Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial. (2019)

  10. Aboulafia, David M   Hematology & Oncology  Google Publications
    Floyd and Delores Jones Cancer Institute at Virginia Mason Medical Center, Seattle, Washington.
    Physician  Clinical Trial  Case Reports 
    Medical school: University of Michigan Medical School (MD, 1983)
    Medicare Accepted
    Disclosed payments in 2021 from 5 biomedical companies, totalling $2,962.84, including $2,250 from  PFIZER INC.
    Subjects: Sarcoma, Kaposi; Antineoplastic Agents; Benzamides; Bortezomib; Doxorubicin
    Categories: Drug Therapy; Therapeutic Use; Pathology; Analogs & Derivatives; Isolation & Purification
    Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042. (2014)
    Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. (2011)

  11. Chiller, Tom M   Infectious Disease  Google Publications
    Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
    Physician  Highly Cited  Highly Published 
    Subjects: Meningitis, Cryptococcal; HIV Infections; Antigens, Fungal; Histoplasmosis; Cryptococcosis
    Categories: Diagnosis; Mortality; Epidemiology; Complications; Prevention & Control; Administration & Dosage
    Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. (2011)
    Multicenter Validation of Commercial Antigenuria Reagents To Diagnose Progressive Disseminated Histoplasmosis in People Living with HIV/AIDS in Two Latin American Countries. (2018)

  12. Heiden, David   Ophthalmology   Google Publications
    Department of Ophthalmology and Pacific Vision Foundation, California Pacific Medical Center, San Francisco, California, USA.
    Physician  Highly Published  Review 
    Disclosed payments in 2021 from 6 biomedical companies, totalling $247.15, including $135.98 from  Ocular Therapeutix, Inc.
    Subjects: Cytomegalovirus Retinitis; HIV Infections; Antiviral Agents; Choroid Diseases; Ophthalmoscopy
    Categories: Diagnosis; Epidemiology; Complications; Methods; Adverse Effects; Drug Therapy
    Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review. (2013)
    Eye examination for early diagnosis of disseminated tuberculosis in patients with AIDS. (2016)

  13. Limper, Andrew H   Pulmonary Disease   Google Publications
    Mayo Clinic College of Medicine, Rochester, MN, USA. Top Hospital
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 79.7/100
    Subjects: Mycoses; Fungal Proteins; Fungi; HIV Infections; Histone Acetyltransferases
    Categories: Epidemiology; Microbiology; Complications; Drug Effects; Drug Therapy; Genetics
    Fungal infections in HIV/AIDS. (2017)
    AIDS-related mycoses: the way forward. (2014)

  14. Krown, Susan E   Medical Oncology   Google Publications
    AIDS Malignancy Consortium, New York, NY, USA. Electronic address: .
    Physician  Highly Published  Clinical Trial 
    Subjects: Sarcoma, Kaposi; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active
    Categories: Therapeutic Use; Drug Therapy; Adverse Effects; Antagonists & Inhibitors
    Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial. (2020)
    Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042. (2014)

  15. Gandhi, Rajesh T   Infectious Disease   Google Publications
    Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA; Infectious Diseases Division and Ragon Institute, Massachusetts General Hospital, GRJ 504, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: . Top Hospital
    Physician  Case Reports 
    Medical school: Harvard Medical School (MD, 1990)
    Medicare Accepted
    Subjects: HIV Infections; Leukoencephalopathy, Progressive Multifocal; Lymph Nodes; AIDS-Related Complex; Acquired Immunodeficiency Syndrome
    Categories: Complications; Etiology; Immunology; Pathology; Mortality; Diagnosis
    Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. (2010)
    Clinical predictors for the aetiology of peripheral lymphadenopathy in HIV-infected adults. (2013)

  16. Cain, Kevin P   Internal Medicine   Google Publications
    U.S. Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, Atlanta, GA 30333, USA.
    Physician 
    Subjects: HIV Infections; Tuberculosis, Pulmonary; Fungemia; Abdomen; Algorithms
    Categories: Complications; Epidemiology; Diagnosis; Diagnostic Imaging
    An algorithm for tuberculosis screening and diagnosis in people with HIV. (2010)
    Bloodstream infections among HIV-infected outpatients, Southeast Asia. (2010)

  17. Sterling, Timothy R   Infectious Disease   Google Publications
    Vanderbilt Tuberculosis Center, Nashville, TN, USA.
    Physician  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 73.2/100
    Subjects: Tuberculosis; HIV Infections; Antitubercular Agents; Isoniazid; Infection Control
    Categories: Drug Therapy; Diagnosis; Prevention & Control; Therapeutic Use; Administration & Dosage; Complications
    Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. (2019)
    Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. (2016)

  18. Kaplan, Jonathan E   Infectious Disease  Google Publications
    Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.
    Physician  Highly Published  Clinical Trial  Review 
    Subjects: HIV Infections; Health Impact Assessment; Trimethoprim, Sulfamethoxazole Drug Combination; Anti-Infective Agents; Review Literature as Topic
    Categories: Prevention & Control; Therapeutic Use; Drug Therapy; Administration & Dosage; Diagnosis; Complications
    Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. (2014)
    Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial. (2019)

  19. Thorne, Jennifer E   Ophthalmology   Google Publications
    Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. Top Hospital
    Physician  Highly Published  Clinical Trial 
    Disclosed payments in 2021 from 14 biomedical companies, totalling $18,600, including $16,750 from  Gilead Sciences, Inc.
    Subjects: Cytomegalovirus Retinitis; Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Visual Fields; Antiviral Agents
    Categories: Epidemiology; Complications; Drug Therapy; Etiology; Pathology; Administration & Dosage
    Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. (2016)
    Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. (2012)

  20. Masur, Henry   Infectious Disease  Google Publications
    George Washington University School of Medicine, Washington, DC, USA.
    Physician  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 86/100
    Subjects: HIV Infections; Pneumonia, Pneumocystis; Anti-Retroviral Agents; Antitubercular Agents; Disease Management
    Categories: Diagnosis; Complications; Mortality; Epidemiology; Therapy; Administration & Dosage
    Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. (2014)
    HIV-associated Pneumocystis pneumonia. (2011)

Note:
  1. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);